{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:41:57Z","timestamp":1792226517191,"version":"4.4.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201343","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T14:34:13Z","timestamp":1532615653000},"page":"e0201343","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?"],"prefix":"10.1371","volume":"13","author":[{"given":"Sakiko","family":"Soutome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-1901","authenticated-orcid":true,"given":"Saki","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Funahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Yanamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"RE Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.joms.2016.12.014","article-title":"Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis","volume":"75","author":"HY Kim","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bjoms.2016.06.015","article-title":"Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients","volume":"54","author":"M Nisi","year":"2016","journal-title":"British J Oral Maxillofac Surg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease stage and mode of therapy are important determinants of treatment outcome for medication-related osteonecrosis of the jaw","volume":"73","author":"SL Ruggiero","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","article-title":"Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases","volume":"70","author":"F Granziani","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.oraloncology.2011.11.004","article-title":"The saxon bisphosphonate register-therapy and prevention of bisphosphonate-related osteonecrosis of the jaws","volume":"48","author":"M Schubert","year":"2012","journal-title":"Oral Oncol"},{"key":"ref7","first-page":"w13605","article-title":"Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years?","volume":"142","author":"C Jacobsen","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"P Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"T M\u00facke","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.oraloncology.2013.05.012","article-title":"Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes","volume":"49","author":"MA Lerman","year":"2013","journal-title":"Oral Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients","volume":"67","author":"TS Lazarovici","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"RE Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"K Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcome of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"R Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"AA Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: A multicenter retrospective study with propensity score matching analysis","volume":"32","author":"S Hayashida","year":"2017","journal-title":"J Bone Miner Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN","author":"A Barasch","year":"2011","journal-title":"J Dent Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients","volume":"26","author":"A Kyrgidis","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonaterelated osteonecrosis of the jaw","volume":"27","author":"K Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","article-title":"Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons","volume":"28","author":"T Yoneda","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?","volume":"43","author":"S Otto","year":"2015","journal-title":"Craniomaxillofac Surg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded activecontrolled phase III trials in cancer patients with bone metastases","volume":"23","author":"F Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronate for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"A Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1248\/bpb.b15-00385","article-title":"Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: A retrospective cohort study","volume":"38","author":"M Kajizono","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series","volume":"123","author":"S Fedele","year":"2012","journal-title":"Am J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study","volume":"41","author":"T Yamazaki","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","article-title":"Tooth extraction in patients on zoledronic acid therapy","volume":"48","author":"M Mozzati","year":"2012","journal-title":"Oral Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.joms.2013.01.006","article-title":"Tooth extractions in intravenous bisphosphonate-treated patients: A refined protocol","volume":"71","author":"M Scoletta","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"SL Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the Jaw (ONJ) diagnosis and management in 2015","volume":"27","author":"A Khan","year":"2016","journal-title":"Osteoporos Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:51:35Z","timestamp":1540216295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201343"}},"subtitle":[],"editor":[{"given":"Jonathan H.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201343","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}